Dose Recommendation for Aripiprazol in Depression Treatment

Introduction to Aripiprazol Dosage

• The American Psychiatric Association recommends starting with a dose of 2.5 mg of aripiprazol for depression treatment, with a possible titration to 5 mg daily to optimize the balance between therapeutic response and adverse effects 1

Efficacy and Safety

• Low doses (2-5 mg) achieve the optimal balance between efficacy, tolerability, and acceptability in the acute treatment of antidepressant-resistant depression, with a lower risk of akathisia and other adverse effects 1

Monitoring and Dose Adjustment

• Monitor patients intensively for akathisia, especially in the first 2-4 weeks, when the risk is higher, and reduce the dose if akathisia occurs 1
• The response to aripiprazol may occur as early as the first week, with 40% of patients achieving remission, and the full response usually occurs within 2-8 weeks 1

Special Considerations

• In elderly patients and slow metabolizers of CYP2D6, the dose should be reduced to minimize the risk of adverse effects 1
• Aripiprazol has a lower risk of extrapyramidal symptoms compared to other antipsychotics and a more favorable metabolic profile than olanzapine or quetiapina 1, 2

Adverse Effects

• Common adverse effects include insomnia, agitation, anxiety, headache, dizziness, or somnolence, and the risk of serotonin syndrome when combined with serotonergic antidepressants 1